The endocannabinoid system as a target for modelling psychosis

Psychopharmacology

Volumn 206, Issue 4, 2009, Pages 551-561

  Koethe, Dagmar ^a,b   Hoyer, Carolin ^a   Leweke, F Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cannabinoids; Endocannabinoid system; Initial prodromal state; Model psychosis; Schizophrenia; THC

Indexed keywords

CANNABIDIOL; CANNABIS; DOPAMINE; DRONABINOL; ENDOCANNABINOID; FLUORODEOXYGLUCOSE F 18;

BEHAVIOR; BRAIN BLOOD FLOW; BRAIN REGION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CROSS LINKING; DISEASE MODEL; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROBIOLOGY; NEUROIMAGING; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANIMALS; ENDOCANNABINOIDS; HUMANS; MODELS, BIOLOGICAL; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 70349652278     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1591-7     Document Type: Review

References (83)

1. F Ames 1958 A clinical and metabolic study of acute intoxication with cannabis sative and its role in the model psychoses J Ment Sci 104 972 999 13621144 1:STN:280:DyaG1M%2FltVKrsQ%3D%3D
2. L Arseneault M Cannon J Witton RM Murray 2004 Causal association between cannabis and psychosis: examination of the evidence Br J Psychiatry 184 110 117 14754822 10.1192/bjp.184.2.110 (Pubitemid 38186851)
3. C Ashton 2001 Pharmacology and effects of cannabis: a brief review Br J Psychiatry 178 101 106 11157422 10.1192/bjp.178.2.101 1:STN:280: DC%2BD3M3lvVKnsQ%3D%3D (Pubitemid 32158071)
4. K Beringer W von Baeyer H Marx 1932 Zur Klinik des Haschischrausches Nervenarzt 5 337 350
5. T Bisogno L Hanus L De Petrocellis S Tchilibon DE Ponde I Brandi AS Moriello JB Davis R Mechoulam V Di Marzo 2001 Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Br J Pharmacol 134 845 852 11606325 10.1038/sj.bjp.0704327 1:CAS:528:DC%2BD3MXotlChsbk%3D
6. SJ Borgwardt P Allen S Bhattacharyya P Fusar-Poli JA Crippa ML Seal V Fraccaro Z Atakan R Martin-Santos C O'Carroll K Rubia PK McGuire 2008 Neural basis of delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition Biol Psychiatry 64 966 673 18589404 10.1016/j.biopsych.2008.05.011 1:CAS:528:DC%2BD1cXhtlCrtbzL
7. MG Bossong BN van Berckel R Boellaard L Zuurman RC Schuit AD Windhorst JM van Gerven NF Ramsey AA Lammertsma RS Kahn 2009 Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum Neuropsychopharmacology 34 759 766 18754005 10.1038/npp.2008.138 1:CAS:528:DC%2BD1MXkvVaksA%3D%3D
8. HD Burns K Van Laere S Sanabria-Bohorquez TG Hamill G Bormans WS Eng R Gibson C Ryan B Connolly S Patel S Krause A Vanko A Van Hecken P Dupont I De Lepeleire P Rothenberg SA Stoch J Cote WK Hagmann JP Jewell LS Lin P Liu MT Goulet K Gottesdiener JA Wagner J de Hoon L Mortelmans TM Fong RJ Hargreaves 2007 [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor Proc Natl Acad Sci U S A 104 9800 9805 17535893 10.1073/pnas.0703472104 1:CAS:528:DC%2BD2sXmsFSmsLc%3D (Pubitemid 47175347)
9. LD Chait JL Perry 1994 Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance Psychopharmacology (Berl) 115 340 349 10.1007/BF02245075 1:CAS:528:DyaK2cXlsFWisLo%3D (Pubitemid 24217093)
10. L Chang EP Chronicle 2007 Functional imaging studies in cannabis users Neuroscientist 13 422 432 17901252 10.1177/1073858406296601 (Pubitemid 47437933)
11. JR Clapper RA Mangieri D Piomelli 2009 The endocannabinoid system as a target for the treatment of cannabis dependence Neuropharmacology 56 Suppl 1 235 243 18691603 10.1016/j.neuropharm.2008.07.018 1:CAS:528:DC%2BD1MXhsVKiuw%3D%3D
12. JA Crippa AW Zuardi GE Garrido L Wichert-Ana R Guarnieri L Ferrari PM Azevedo-Marques JE Hallak PK McGuire G Filho Busatto 2004 Effects of cannabidiol (CBD) on regional cerebral blood flow Neuropsychopharmacology 29 417 426 14583744 10.1038/sj.npp.1300340 1:CAS:528:DC%2BD2cXksl2gsA%3D%3D (Pubitemid 38175159)
13. HV Curran C Brignell S Fletcher P Middleton J Henry 2002 Cognitive and subjective dose-response effects of acute oral delta(9)-tetrahydrocannabinol (THC) in infrequent cannabis users Psychopharmacology (Berl) 164 61 70 10.1007/s00213-002-1169-0 1:CAS:528:DC%2BD38Xns1OgsbY%3D (Pubitemid 35203843)
14. WS Dalton R Martz L Lemberger BE Rodda RB Forney 1976 Influence of cannabidiol on delta-9-tetrahydrocannabinol effects Clin Pharmacol Ther 19 300 309 770048 1:CAS:528:DyaE28XhsVCqu7g%3D
15. B Dean S Sundram R Bradbury E Scarr D Copolov 2001 Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use Neuroscience 103 9 15 11311783 10.1016/S0306-4522(00)00552-2 1:CAS:528:DC%2BD3MXislaqsrw%3D (Pubitemid 32304342)
16. WA Devane FA Dysarz III MR Johnson LS Melvin AC Howlett 1988 Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 605 613 2848184 1:CAS:528:DyaL1MXovVersQ%3D%3D
17. V Di Marzo 2008 Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 438 455 18446159 10.1038/nrd2553 (Pubitemid 351649182)
18. CD D'Souza E Perry L MacDougall Y Ammerman T Cooper Y-T Wu G Braley R Gueorguieva JH Krystal 2004 The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis Neuropsychopharmacology 29 1558 1572 15173844 10.1038/sj.npp.1300496 (Pubitemid 38982249)
19. DC D'Souza WM Abi-Saab S Madonick K Forselius-Bielen A Doersch G Braley R Gueorguieva TB Cooper JH Krystal 2005 Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction Biol Psychiatry 57 594 608 15780846 10.1016/j.biopsych.2004.12.006 (Pubitemid 40409699)
20. DC D'Souza G Braley R Blaise M Vendetti S Oliver B Pittman M Ranganathan S Bhakta Z Zimolo T Cooper E Perry 2008 Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of delta-9-tetrahydrocannabinol in humans Psychopharmacology (Berl) 198 587 603 10.1007/s00213-007-1042-2
21. DC D'Souza M Ranganathan G Braley R Gueorguieva Z Zimolo T Cooper E Perry J Krystal 2008 Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis Neuropsychopharmacology 33 2505 2516 18185500 10.1038/sj.npp.1301643
22. SM Eggan T Hashimoto DA Lewis 2008 Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia Arch Gen Psychiatry 65 772 784 18606950 10.1001/archpsyc.65.7.772 (Pubitemid 351957703)
23. MA Elsohly D Slade 2005 Chemical constituents of marijuana: the complex mixture of natural cannabinoids Life Sci 78 539 548 16199061 10.1016/j.lfs.2005.09.011 1:CAS:528:DC%2BD2MXht1ejsrfJ (Pubitemid 41653504)
24. P Fusar-Poli JA Crippa S Bhattacharyyay SJ Borgwardt P Allen R Martin-Santos M Seal SA Surguladze C O'Carrol Z Atakan AW Zuardi PK McGuire 2009 Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing Arch Gen Psychiatry 66 95 105 19124693 10.1001/archgenpsychiatry.2008.519 1:CAS:528:DC%2BD1MXhslSrur8%3D
25. Y Gaoni R Mechoulam 1964 Isolation, structure and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1646 1647 10.1021/ja01062a046 1:CAS:528:DyaF2cXkt1GhtLs%3D
26. A Giuffrida LH Parsons TM Kerr FR de Fonseca M Navarro D Piomelli 1999 Dopamine activation of endogenous cannabinoid signaling in dorsal striatum Nat Neurosci 2 358 363 10204543 10.1038/7268 1:CAS:528:DyaK1MXitFGjs7s%3D (Pubitemid 30491279)
27. A Giuffrida FM Leweke CW Gerth D Schreiber D Koethe J Faulhaber J Klosterkotter D Piomelli 2004 Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms Neuropsychopharmacology 29 2108 2114 15354183 10.1038/sj.npp.1300558 1:CAS:528:DC%2BD2cXoslSku7w%3D (Pubitemid 39486563)
28. M Glass M Dragunow RL Faull 1997 Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain Neuroscience 77 299 318 9472392 10.1016/S0306-4522(96)00428-9 1:CAS:528:DyaK2sXhs1Gms7w%3D (Pubitemid 27079604)
29. H Häfner W an der Heiden 1999 The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies Eur Arch Psychiatry Clin Neurosci 249 Suppl 4 14 26 10654105
30. M Herkenham AB Lynn MD Little MR Johnson LS Melvin BR de Costa KC Rice 1990 Cannabinoid receptor localization in brain Proc Natl Acad Sci USA 87 1932 1936 2308954 10.1073/pnas.87.5.1932 1:CAS:528:DyaK3cXhsFWktLs%3D
31. LE Hollister 1973 Cannabidiol and cannabinol in man Experientia 29 825 826 4724713 10.1007/BF01946311 1:CAS:528:DyaE3sXltVSktr4%3D
32. LE Hollister H Gillespie 1975 Interactions in man of delta-9- tetrahydrocannabinol. II. Cannabinol and cannabidiol Clin Pharmacol Ther 18 80 83 1097148 1:CAS:528:DyaE2MXlsVajtb4%3D
33. H Isbell CW Gorodetzsky D Jasinski U Claussen F von Spulak F Korte 1967 Effects of (-)delta-9-trans-tetrahydrocannabinol in man Psychopharmacologia 11 184 188 4871478 10.1007/BF00401256 1:CAS:528:DyaF2sXksFaltbY%3D
34. A Johns 2001 Psychiatric effects of cannabis Br J Psychiatry 178 116 122 11157424 10.1192/bjp.178.2.116 1:STN:280:DC%2BD3M3lvVKntw%3D%3D (Pubitemid 32158073)
35. M Kano T Ohno-Shosaku Y Hashimotodani M Uchigashima M Watanabe 2009 Endocannabinoid-mediated control of synaptic transmission Physiol Rev 89 309 380 19126760 10.1152/physrev.00019.2008 1:CAS:528:DC%2BD1MXit1Cqtrk%3D
36. IG Karniol I Shirakawa N Kasinski A Pfeferman EA Carlini 1974 Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man Eur J Pharmacol 28 172 177 4609777 10.1016/0014-2999(74)90129-0 1:CAS:528: DyaE28XjvV2gsw%3D%3D
37. IG Karniol RN Takahashi RE Musty 1974 Effects of delta9- tetrahydrocannabinol and cannabinol on operant performance in rats Arch Int Pharmacodyn Ther 212 230 237 4447406 1:CAS:528:DyaE28XjvVyqsg%3D%3D
38. JM Kirk H de Wit 1999 Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users Pharmacol Biochem Behav 63 137 142 10340534 10.1016/S0091-3057(98)00264-0 1:CAS:528:DyaK1MXjtFSlsr0%3D (Pubitemid 29206572)
39. JM Kirk P Doty H De Wit 1998 Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol Pharmacol Biochem Behav 59 287 293 9476972 10.1016/S0091-3057(97)00414-0 1:CAS:528:DyaK1cXmsVOrug%3D%3D (Pubitemid 28072719)
40. D Koethe CW Gerth MA Neatby A Haensel M Thies U Schneider HM Emrich J Klosterkotter F Schultze-Lutter FM Leweke 2006 Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness Schizophr Res 88 142 150 17005373 10.1016/j.schres.2006.07.023 (Pubitemid 44693257)
41. D Koethe IC Llenos JR Dulay C Hoyer EF Torrey FM Leweke S Weis 2007 Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression J Neural Transm 114 1055 1063 17370106 10.1007/s00702-007-0660-5 1:CAS:528:DC%2BD2sXotFWrtro%3D
42. D Koethe A Giuffrida D Schreiber M Hellmich F Schultze-Lutter S Ruhrmann J Klosterkotter D Piomelli FM Leweke 2009 Anandamide elevation in CSF of prodromal states of schizophrenia Br J Psychiatry 194 371 372 19336792 10.1192/bjp.bp.108.053843
43. D Koethe L Kranaster C Hoyer S Gross MA Neatby F Schultze-Lutter S Ruhrmann J Klosterkotter M Hellmich FM Leweke 2009 Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naive and treated schizophrenia Eur Arch Psychiatry Clin Neurosci 259 195 202 19165523 10.1007/s00406-008-0851-6
44. FM Leweke D Koethe 2008 Cannabis and psychiatric disorders: it is not only addiction Addict Biol 13 264 275 18482435 10.1111/j.1369-1600.2008.00106.x (Pubitemid 351692982)
45. FM Leweke A Giuffrida U Wurster HM Emrich D Piomelli 1999 Elevated endogenous cannabinoids in schizophrenia NeuroReport 10 1665 1669 10501554 10.1097/00001756-199906030-00008 1:CAS:528:DyaK1MXksFaltLc%3D
46. 9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man Psychopharmacology 142 230 235 10208314 10.1007/s002130050884 1:CAS:528:DyaK1MXisVCiu74%3D (Pubitemid 29200149)
47. FM Leweke U Schneider M Radwan E Schmidt HM Emrich 2000 Different effects of nabilone and cannabidiol on binocular depth inversion in man Pharmacol Biochem Behav 66 175 181 10837858 10.1016/S0091-3057(00)00201-X 1:CAS:528:DC%2BD3cXjs1Cnsrw%3D (Pubitemid 30317532)
48. FM Leweke A Giuffrida D Koethe D Schreiber BM Nolden L Kranaster MA Neatby M Schneider CW Gerth M Hellmich J Klosterkotter D Piomelli 2007 Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use Schizophr Res 94 29 36 17566707 10.1016/j.schres.2007.04.025 (Pubitemid 47031599)
49. R Maldonado O Valverde F Berrendero 2006 Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 225 232 16483675 10.1016/j.tins.2006.01.008 1:CAS:528:DC%2BD28Xjs1Wmurw%3D
50. RJ Mathew WH Wilson SR Tant 1989 Acute changes in cerebral blood flow associated with marijuana smoking Acta Psychiatr Scand 79 118 128 2923005 10.1111/j.1600-0447.1989.tb08579.x 1:STN:280:DyaL1M7mtlyisg%3D%3D
51. RJ Mathew WH Wilson DF Humphreys JV Lowe KE Wiethe 1992 Regional cerebral blood flow after marijuana smoking J Cereb Blood Flow Metab 12 750 758 1324250 1:STN:280:DyaK38znt1Krtg%3D%3D
52. RJ Mathew WH Wilson RE Coleman TG Turkington TR DeGrado 1997 Marijuana intoxication and brain activation in marijuana smokers Life Sci 60 2075 2089 9180362 10.1016/S0024-3205(97)00195-1 1:CAS:528:DyaK2sXjtVClt7s%3D (Pubitemid 27239657)
53. RJ Mathew WH Wilson NY Chiu TG Turkington TR Degrado RE Coleman 1999 Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration Acta Psychiatr Scand 100 67 75 10442442 10.1111/j.1600-0447.1999. tb10916.x 1:CAS:528:DyaK1MXkslOhsLY%3D
54. RJ Mathew WH Wilson TG Turkington TC Hawk RE Coleman TR DeGrado J Provenzale 2002 Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography Psychiatry Research: Neuroimaging 116 173 185 12477601 10.1016/S0925-4927(02)00069-0 1:CAS:528:DC%2BD3sXhsV2is70%3D (Pubitemid 35441321)
55. LA Matsuda SJ Lolait MJ Brownstein AC Young TI Bonner 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561 564 2165569 10.1038/346561a0 1:CAS:528:DyaK3cXls1Ghu7w%3D (Pubitemid 20238806)
56. J McDonald L Schleifer JB Richards H de Wit 2003 Effects of THC on behavioral measures of impulsivity in humans Neuropsychopharmacology 28 1356 1365 12784123 10.1038/sj.npp.1300176 1:CAS:528:DC%2BD3sXkvVKmsL0%3D (Pubitemid 41070907)
57. TH Moore S Zammit A Lingford-Hughes TR Barnes PB Jones M Burke G Lewis 2007 Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 319 328 17662880 10.1016/S0140-6736(07)61162-3 (Pubitemid 47094993)
58. Moreau de Tours J-J (1845) Du hachisch et de l'aliénation mentale, Études psychologiques. Fortin et Masson, Fortin et Masson
59. CJ Morgan HV Curran 2008 Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis Br J Psychiatry 192 306 307 18378995 10.1192/bjp.bp.107.046649 (Pubitemid 351692406)
60. S Munro KL Thomas M Abu Shaar 1993 Molecular characterization of a peripheral receptor for cannabinoids Nature 365 61 65 7689702 10.1038/365061a0 1:CAS:528:DyaK3sXmsVWiurk%3D (Pubitemid 23305569)
61. A Ohlsson JE Lindgren A Wahlen S Agurell LE Hollister HK Gillespie 1980 Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking Clin Pharmacol Ther 28 409 416 6250760 1:CAS:528:DyaL3cXlvFOnu70%3D
62. DS O'Leary RI Block M Flaum SK Schultz LL Boles Ponto GL Watkins RR Hurtig NC Andreasen RD Hichwa 2000 Acute marijuana effects on rCBF and cognition: a PET study NeuroReport 11 3835 3841 11117500
63. DS O'Leary RI Block JA Koeppel M Flaum SK Schultz NC Andreasen LB Ponto GL Watkins RR Hurtig RD Hichwa 2002 Effects of smoking marijuana on brain perfusion and cognition Neuropsychopharmacology 26 802 816 12007751 10.1016/S0893-133X(01)00425-0 (Pubitemid 34455033)
64. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 16968947 10.1124/pr.58.3.2 1:CAS:528:DC%2BD28XhtVOhtLfO (Pubitemid 44394908)
65. M Perez-Reyes MC Timmons MA Lipton HD Christensen KH Davis ME Wall 1973 A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man Experientia 29 1009 1010 4582081 10.1007/BF01930433 1:CAS:528:DyaE3sXlt1Wqtbg%3D
66. D Piomelli 2003 The molecular logic of endocannabinoid signalling Nat Rev, Neurosci 4 873 884 10.1038/nrn1247 1:CAS:528:DC%2BD3sXosFOktrY%3D (Pubitemid 37351427)
67. D Piomelli A Giuffrida A Calignano F Rodriguez de Fonseca 2000 The endocannabinoid system as a target for therapeutic drugs Trends Pharmacol Sci 21 218 224 10838609 10.1016/S0165-6147(00)01482-6 1:CAS:528:DC%2BD3cXjvFKjtbo%3D (Pubitemid 30331091)
68. M Ranganathan DC D'Souza 2006 The acute effects of cannabinoids on memory in humans: a review Psychopharmacology (Berl) 188 425 444 10.1007/s00213-006- 0508-y 1:CAS:528:DC%2BD28XhtVeqsLnL (Pubitemid 44498214)
69. CF Schaefer CG Gunn KM Dubowski 1977 Dose-related heart-rate, perceptual, and decisional changes in man following marihuana smoking Percept Mot Skills 44 3 16 840603 1:STN:280:DyaE2s7isV2ruw%3D%3D
70. D Schreiber S Harlfinger BM Nolden CW Gerth U Jaehde E Schomig J Klosterkotter A Giuffrida G Astarita D Piomelli F Markus Leweke 2007 Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry Anal Biochem 361 162 168 17196922 10.1016/j.ab.2006.11.027 1:CAS:528:DC%2BD2sXhtVKgtbs%3D (Pubitemid 46135393)
71. Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cambridge
72. N Solowij PT Michie 2007 Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 32 30 52 17245472
73. N Solowij R Stephens RA Roffman T Babor 2002 Does marijuana use cause long-term cognitive deficits? JAMA 287 2653 2654 12020296 10.1001/jama.287.9. 1123 author reply 2654
74. N Solowij RS Stephens RA Roffman T Babor R Kadden M Miller K Christiansen B McRee J Vendetti 2002 Cognitive functioning of long-term heavy cannabis users seeking treatment J Am Med Assoc 287 1123 1131 10.1001/jama.287.9.1123
75. KM Spencer PG Nestor MA Niznikiewicz DF Salisbury ME Shenton RW McCarley 2003 Abnormal neural synchrony in schizophrenia J Neurosci 23 7407 7411 12917376 1:CAS:528:DC%2BD3sXms1Wnt74%3D
76. PJ Uhlhaas C Haenschel D Nikolic W Singer 2008 The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia Schizophr Bull 34 927 943 18562344 10.1093/schbul/sbn062
77. ND Volkow H Gillespie N Mullani L Tancredi C Grant M Ivanovic L Hollister 1991 Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose Psychiatry Res 40 69 78 1658842 10.1016/0165-1781(91)90146-G 1:CAS:528:DyaK3MXmslSnt7g%3D
78. SR Wachtel MA ElSohly SA Ross J Ambre H de Wit 2002 Comparison of the subjective effects of delta(9)-tetrahydrocannabinol and marijuana in humans Psychopharmacology 161 331 339 12073159 10.1007/s00213-002-1033-2 1:CAS:528:DC%2BD38XlvFertrg%3D (Pubitemid 34595783)
79. ME Wall BM Sadler D Brine H Taylor M Perez-Reyes 1983 Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women Clin Pharmacol Ther 34 352 363 6309462 1:CAS:528:DyaL3sXlvVOjsbg%3D
80. A Weinstein O Brickner H Lerman M Greemland M Bloch H Lester R Chisin R Mechoulam R Bar-Hamburger N Freedman E Even-Sapir 2008 Brain imaging study of the acute effects of delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana Psychopharmacology (Berl) 196 119 131 10.1007/s00213-007-0940-7 1:CAS:528:DC%2BD1cXhsV2ku7w%3D
81. RI Wilson RA Nicoll 2002 Endocannabinoid signaling in the brain Science 296 678 682 11976437 10.1126/science.1063545 1:CAS:528:DC%2BD38XjtlOhtb4%3D (Pubitemid 34441983)
82. AW Zuardi I Shirakawa E Finkelfarb IG Karniol 1982 Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects Psychopharmacology 76 245 250 6285406 10.1007/BF00432554 1:CAS:528: DyaL38XktFKlu74%3D
83. L Zuurman AE Ippel E Moin JM van Gerven 2009 Biomarkers for the effects of cannabis and THC in healthy volunteers Br J Clin Pharmacol 67 5 21 19133057 10.1111/j.1365-2125.2008.03329.x 1:CAS:528:DC%2BD1MXitFyqurk%3D